CAIHL read · Jun 11, 2026
AI medical advice changes care decisions of most users: survey
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
patient
Patients, families, and care partners are the primary users of this AI.
Hosting
public
Hosted for public use (ChatGPT, Claude, consumer apps). Anyone with a device can use it.
Interests
mixed
Multiple stakeholder interests in tension; the alignment is not stable.
Agency
expanding
Expands patient capabilities, supports their questions, increases their ability to act on their own values across and beyond health systems.
Editor's CAIHL read
One-sentence synthesis
Behavior-change measurement on AI medical advice; expanding patient agency in the decision layer.
In the scan
How this item appeared in the daily scan
Editor's note: Behavior-change reporting at this scale is the data point the AMA's transparency policy now has to be built against. The chatbot is no longer just an information source the patient compared notes from; it is the source that moved the decision.
Summary: Fierce Pharma: Pharma-trade coverage of survey data showing that AI medical advice is materially changing the care decisions of most users who consult it — a behavioral effect that goes past 'consult and ignore'.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.